The online version of this article (doi:10.1186/1465-9921-15-40) contains supplementary material, which is available to authorized users.
Dr. Camargo has provided consultation for AstraZeneca, Genentech, GlaxoSmithKline, Merck, Novartis, and Pfizer, and received research grants from AstraZeneca and Novartis. The other authors have no financial relationships relevant to this article to disclose.
Conception and design: KH, YT, and CC; Analysis and interpretation: KH, YT, CT, DB, and CC; Drafting the manuscript for important intellectual content: KH, YT, CT, DB, and CC. All authors read and approved the final manuscript.
Little is known about patients who frequently visit the emergency department (ED) for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). We aimed to quantify the proportion and characteristics of patients with frequent ED visits for AECOPD and associated healthcare utilization.
We conducted a retrospective cohort study of adults aged ≥40 years with at least one ED visit for AECOPD between 2010 and 2011, derived from population-based all-payer data of State ED and Inpatient Databases for two large and diverse states: California and Florida. Outcome measures were frequency of ED visits for AECOPD, 30-day ED revisits, subsequent hospitalizations, near-fatal events (AECOPD involving mechanical ventilation), and charges for both ED and inpatient services (available only for Florida) during the year after the first ED visit.
The analytic cohort comprised 98,280 unique patients with 154,736 ED visits for AECOPD. During the 1-year period, 29.4% (95% CI, 29.1%-29.7%) of the patients had two or more (frequent) visits, accounting for 55.2% (95% CI, 54.9%-55.4%) of all ED visits for AECOPD. In the multivariable model, significant predictors of frequent ED visits were age 55–74 years (vs. 40–54 years), male sex, non-Hispanic white or black race, Medicaid insurance (vs. private), and lower median household income (all P < 0.001). At the visit-level, 12.3% of ED visits for AECOPD were 30-day revisit events (95% CI, 12.1%-12.4%). Additionally, 62.8% of ED visits for AECOPD (95% CI, 62.6%-63.0%) resulted in a hospitalization; patients with frequent ED visits comprised 55.5% (95% CI, 55.2%-55.8%) of all hospitalizations. Furthermore, 7.3% (95% CI, 7.3%-7.5%) of ED visits for AECOPD led to a near-fatal event; patients with frequent ED visits accounted for 64.4% (95% CI, 63.5%-65.3%) of all near-fatal events. Total charges for AECOPD were $1.94 billion (95% CI, $1.90-1.97 billion) in Florida; patients with frequent ED visits accounted for $1.07 billion (95% CI, $1.04-1.09 billion).
In this large cohort study, we found that 29% had frequent ED visits for AECOPD and that lower socioeconomic status was significantly associated with a higher frequency of ED visits. Individuals with frequent ED visits for AECOPD accounted for a substantial amount of healthcare utilization and financial burden.
Kanner RE, Anthonisen NR, Connett JE, Group LHSR: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001, 164: 358-364. 10.1164/ajrccm.164.3.2010017. PubMedCrossRef
The Global Initiative for Chronic Obstructive Lung Disease (GOLD). NHLBI/WHO Gobal Strategy for the Diagnosis, Management and Prevention of COPD. [ http://www.goldcopd.org/]
Healthy people 2020. [ http://www.healthypeople.gov/2020/default.aspx]
Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA: Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010, 363: 1128-1138. 10.1056/NEJMoa0909883. PubMedCrossRef
Overview of the State Emergency Department Databases (SEDD). Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. [ http://www.hcup-us.ahrq.gov/seddoverview.jsp]
Overview of the State Inpatient Databases (SID). Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. [ http://www.hcup-us.ahrq.gov/sidoverview.jsp]
National Center for Health Statistics: Centers for Disease Control and Prevention. [ http://www.cdc.gov/nchs/]
Healthcare Cost and Utilization Project Comorbidity Software. [ http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp]
Consumer price index. United States Department of Labor, Bureau of Labor Statistics. [ http://www.bls.gov/cpi/home.htm]
McCullagh P, Nelder JA: Generalized Linear Models (Monographs on statistics and applied probability 37). 1989, London: Chapman Hall
The Agency for Healthcare Research and Quality: Readmissions for chronic obstructive pulmonary disease. 2008, [ http://www.hcup-us.ahrq.gov/reports/statbriefs/sb121.jsp]
Setse RW, Euler GL, Gonzalez-Feliciano AG, Bryan LN, Furlow C, Weinbaum CM, Singleton JA: Influenza Vaccination Coverage—United States, 2000–2010. MMWR Surveill Summ. 2011, 60: 38-41. PubMed
Centers for Disease Control and Prevention: Trends in Current Cigarette Smoking Among high Hschool Students and Adults, United States, 1965--2010. 2011, Atlanta, GA: US Department of Health and Human Services; 2011
Lange P, Marott JL, Vestbo J, Ingebrigtsen TS, Nordestgaard BG: Socioeconomic Status and Prognosis of COPD in Denmark. COPD. 2014, [Epub ahead of print]
Prevention quality indicators overview. [ http://www.qualityindicators.ahrq.gov/modules/pqi_overview.aspx]
Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ: Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010, 182: 598-604. 10.1164/rccm.200912-1843CC. PubMedCrossRef
Population estimates. [ http://www.census.gov/popest/]
Effing T, Monninkhof EM, van der Valk PD, van der Palen J, van Herwaarden CL, Partidge MR, Walters EH, Zielhuis GA: Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007, CD002990-4
- Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
David FM Brown
Carlos A Camargo Jr
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II